Lung Neoplasms: all 7,334 studies
Page 47 of 74. Open to participants first (1,555), then studies with results posted, then the rest; newest registration first within each.
- Mediastinal Staging Accuracy of a Selective Lymphadenectomy Strategy in Early Stage NSCLC (ECTOP-1003)CompletedNCT03216551
- Phase Ib/II Study of Chiauranib in Patients With Small Cell Lung CancerCompletedNCT03216343Phase 1
- X-396 Capsule in Patients With ALK-positive Non-small Cell Lung Cancer Previously Treated With CrizotinibActive, not recruitingNCT03215693Phase 2
- Development of Patient Tailored Guideline of Physical Activity for Lung CancerStatus unknownNCT03215537Not applicable
- Twice-daily SIB Radiotherapy Versus Standard Radiotherapy for Patients With SCLCCompletedNCT03214003Not applicable
- Phase 1 Study of CK-301 (Cosibelimab) as a Single Agent in Subjects With Advanced CancersActive, not recruitingNCT03212404Phase 1
- ENB and Photodynamic Therapy in the Treatment for Early Lung CancerStatus unknownNCT03211078Not applicable
- Cerebral Prophylactic Irradiation With Saving Hippocampus and AmygdalaTerminatedNCT03209128
- A Phase IB/II Study of Alectinib Combined With Cobimetinib in Advanced ALK-Rearranged (ALK+) NSCLCActive, not recruitingNCT03202940Phase 1/2
- Apatinib Combine With Platinum-Based Doublet Chemotherapy for First-line Treatment of Advanced NSCLCStatus unknownNCT03201146Phase 1/2
- The Lung Screening, Tobacco and Health ProjectCompletedNCT03200236Phase 3
- Prognostic PET/CT Model in Non Small Cell Lung CancerCompletedNCT03199599
- Clinical Trial of Metastasis Inhibitor NP-G2-044 in Patients With Advanced or Metastatic Treatment-Refractory Solid Tumor MalignanciesCompletedNCT03199586Phase 1
- Clinical Efficacy and Safety of NK and NKT Cells Infusion in Patients With Non Small Cell Lung CancerStatus unknownNCT03198923Phase 1
- Vapor Ablation for Localized Cancer Lesions of the Lung (VAPORIZE)CompletedNCT03198468Not applicable
- Huaier Granule for Prevention of Recurrence and Metastasis of Stage II and III Non-small Cell Lung Cancer (NSCLC)TerminatedNCT03198117Not applicable
- mil60 Versus Bevacizumab in Patients With Treatment-naïve Non-squamous Non-small Cell Lung CancerCompletedNCT03196986Phase 3
- To Predict Efficacy by Detecting Circulating Endothelial Cell Subsets and Blood Perfusion Parameters Changes in Vivo Tumor in Study of QL1101 and Avastin® in Patients With Non-squamous Non-small Cell Lung CancerStatus unknownNCT03195569
- Efficacy and Safety of Maintenance Apatinib Combined With Pemetrexed in Advanced Non-squamous Non-small Cell Lung Cancer PatientsWithdrawnNCT03190239Phase 2
- A Hospital Based Survey on Lung Cancer Related-pain in Northern ChinaStatus unknownNCT03189277
- Comparison of Diagnostic and Therapeutic Efficacy of EBUS-TBNA/EUS-FNA and TEMLA in Operable NSCLC.CompletedNCT03188562Not applicable
- Comparison of Sublobar Resection and Lobectomy to Treat Lung CancerStatus unknownNCT03185754Not applicable
- Safety and Efficiency of γδ T Cell Against Lung CancerCompletedNCT03183232Phase 1/2
- Early Detection of Lung CancerActive, not recruitingNCT03181256
- Clinical Validation of the M5L Lung CADCompletedNCT03179150
- Expanded Access For Lorlatinib For Patients With Non Small Cell Lung Cancer ALK Positive or ROS1 PositiveNo longer availableNCT03178071
- Pirfenidone Combined With Standard First-Line Chemotherapy in Advanced-Stage Lung NSCLCCompletedNCT03177291Phase 1
- ctDNA Dynamic Monitoring and Its Role of Prognosis in Stage I NSCLS by NGSCompletedNCT03172156
- Frequency of EGFR and KRAS Mutations and Clinical-prognostic Correlation in Brazilian Lung Cancer PatientsCompletedNCT03171636
- Study of Palbociclib in Combination With Binimetinib for Patients With Advanced KRAS Mutant Non-Small Cell Lung CancerCompletedNCT03170206Phase 1
- QUILT-3.044: NANT Non-small Cell Lung Cancer (NSCLC) Vaccine: Combination Immunotherapy in Subjects With NSCLC Who Have Progressed After Treatment With PD-1/PD-L1 InhibitorsWithdrawnNCT03169738Phase 1/2
- Efficacy and Safety of QL1101 and Avastin® Respectively Combined With Paclitaxel and Carboplatin in the First-line Treatment of Non-squamous Non-small Cell Lung CancerCompletedNCT03169335Phase 3
- Personalized Therapeutic Anti-tumor Vaccine With Pembrolizumab and Standard of Care Chemotherapy in Squamous Non-Small Cell Lung Cancer and Extensive Stage Small Cell Lung CancerWithdrawnNCT03166254Phase 1
- APatinib Plus Chemotherapy vErsus Chemotherapy As First-line Treatment for Advanced NSCLCWithdrawnNCT03164694Phase 2
- First-in-Human Positron Emission Tomography Study Using the 18F-αvβ6-Binding-PeptideActive, not recruitingNCT03164486Early Phase 1
- A Feasibility Study of Unsupervised, Pre-operative Exercise Program for Patients Scheduled for Lung Cancer SurgeryCompletedNCT03162718Not applicable
- Molecular Profiling in Small Cell Lung CancerStatus unknownNCT03162705
- Bone Metastasis on the Survival of Gefitinib Effective PatientsCompletedNCT03157310Not applicable
- Analysis of Soluble Mediators,Cytokines and FACs as Prognostic Factors in Advanced Non-squamous Lung CarcinomaCompletedNCT03156868
- Effect of Genetic Polymorphisms on Platinum Based Chemotherapy in Non Small Cell Lung CancerStatus unknownNCT03154242
- Icotinib Combined With SBRT for Patients With Metastatic Non-squamous NSCLC With EGFR MutationStatus unknownNCT03153358Phase 2
- Comparison of Robot Assisted Thoracic Surgery With Video Assisted Thoracic Surgery in Case of Lung CancerStatus unknownNCT03152071Not applicable
- 18F-FSPG PET/CT Imaging in Patients With CancersStatus unknownNCT03144622
- Standard Treatment +/- SBRT in Solid Tumors Patients With Between 1 and 5 Bone-only MetastasesActive, not recruitingNCT03143322Not applicable
- Erector Spinae Plane Block Versus Paravertebral Block During Non-intubated Thoracoscopic Lung Resections.TerminatedNCT03137576Not applicable
- Resistance & Activating Mutations Diagnosed Among NSCLC Community Dwelling EGFR Mutation Positive PatientsCompletedNCT03137264
- Tissue Microarrays (TMAs) Construction in Lung Cancer SamplesCompletedNCT03136523
- Apatinib and Etoposide as the Maintenance Therapy in Extensive-stage Small Cell Lung Cancer After First-line ChemotherapyStatus unknownNCT03135977Phase 2
- A Study of SHR-1210 in Combination With Pemetrexed and Carboplatin in Subjects With Non-squamous NSCLCCompletedNCT03134872Phase 3
- PATHOS Study Pain Assessment in Thoracic Oncologic SurgeryCompletedNCT03134729Not applicable
- Robot-assisted vs VATS Lobectomy for NSCLCCompletedNCT03134534Not applicable
- Nivolumab in the Real World: Analysis of the Expanded Use in Spanish PatientCompletedNCT03132493
- Intratumoral Gene Mediated Cytotoxic Immunotherapy in Patients With Resectable Non-Small Cell Lung CancerCompletedNCT03131037Phase 1
- Phase I Study of a Selective ALK Inhibitor PLB1003 in Patients With ALK+ NSCLC.Status unknownNCT03130881Phase 1
- Durvalumab and Tremelimumab for Adjuvant Therapy of Resected NSCLCWithdrawnNCT03130764Phase 2
- A Study of the Correlation Between CRF, Survival and Physiological Factors in NSCLC Patients Under ChemotherapyStatus unknownNCT03130192
- An Exploration of Apatinib Combined With S-1 in Patients With Advanced Non-small Cell Lung CancerCompletedNCT03129256Phase 2
- A Study of Apatinib Plus Docetaxel for Treatment of Advanced Non-squamous Non-small Cell Lung Cancer With Bone MetastasesStatus unknownNCT03127319Phase 2
- A Study of Tarceva vs. Avastin+Tarceva for Advanced NSCLC With EGFR m(+)Status unknownNCT03126799Phase 2
- β-elemene Combine With EGFR-TKI for Advanced EGFR-TKI-resistant NSCLCStatus unknownNCT03123484Phase 2
- Endostar First-line Treatment of Advanced NSCLCStatus unknownNCT03123445Phase 2
- Nivolumab in Treating Patients With Advanced Metastatic Non-small Cell Lung CancerWithdrawnNCT03121417Phase 2
- Local Non-salvage Radiotherapy for Synchronous Oligometastatic Non-small-cell Lung Cancer.Status unknownNCT03119519Phase 2
- Modulation of Anti-tumor T Cell Responses in Cancer Patients Treated by Concomitant RadiochemotherapyCompletedNCT03117946Not applicable
- Recombinant Endostatin Combined With Vinorelbine and Cisplatin in Patients With Advanced Non-small Cell Lung CancerCompletedNCT03117335Phase 3
- Phase Ib/II Study of M3814 With Etoposide and Cisplatin in Small Cell Lung Cancer (SCLC) Extensive Disease (ED)TerminatedNCT03116971Phase 1
- Concordance of Inivata Liquid Biopsy With Standard Tissue BiopsyCompletedNCT03116633
- A Simple Walking Program to Enhance Concurrent Chemoradiotherapy DeliveryCompletedNCT03115398Not applicable
- Abscopal Effect of Radiation in Combination With rhGM-CSF for Metastatic Non-small Cell Lung CancerCompletedNCT03113851Phase 2
- Mediastinal Lymph Node Dissection in Conjunction With Pulmonary Metastasectomy From Colorectal CancerStatus unknownNCT03113318Not applicable
- Acceptance and Commitment Therapy in Improving Well-Being in Patients With Stage III-IV Cancer and Their PartnersCompletedNCT03112668Not applicable
- Stereotactic Body Radiation Therapy With or Without Nivolumab in Treating Patients With Stage I-IIA or Recurrent Non-small Cell Lung CancerActive, not recruitingNCT03110978Phase 2
- Thoracic Surgery Combined With Intrathoracic Hyperthermic Perfusion for Advanced Lung Cancer / Esophageal CancerWithdrawnNCT03110939Not applicable
- Circulating Exosome RNA in Lung Metastases of Primary High-Grade OsteosarcomaActive, not recruitingNCT03108677
- Vistusertib (AZD2014) Monotherapy in Relapsed Small Cell Lung Cancer Patients Harboring RICTOR AmplificationTerminatedNCT03106155Phase 2
- Real-time Activity Monitoring to Prevent Admissions During RadioTherapyCompletedNCT03102229Not applicable
- Observation Study of Patients With Non-Small Cell Lung Cancer and Esophageal Cancer Treated With Chemo-Radiation Followed by SurgeryCompletedNCT03095209
- Dynamic Perfusion Computed Tomography in Patients With Localized Non-small Cell Lung CancerCompletedNCT03091816
- Study of Nivolumab Verses Nivolumab and Ipilimumab Combination in EGFR Mutant Non-small Cell Lung CancerTerminatedNCT03091491Phase 2
- Prophylaxis of Venous Thromboembolism in Advanced Lung Cancer (PROVE)TerminatedNCT03090880Phase 3
- Ceritinib + Trametinib in Patients With Advanced ALK-Positive Non-Small Cell Lung Cancer (NSCLC)TerminatedNCT03087448Phase 1
- Incidence of SCLN Metastasis in Patients Referred for EBUS-TBNAWithdrawnNCT03087305
- Phase II Lung Metcore - Preoperative Metformin for Lung CancerCompletedNCT03086733Phase 2
- A Study on the Safety and Tolerability of Rovalpituzumab Tesirine in Japanese Patients With Advanced, Recurrent Small Cell Lung CancerCompletedNCT03086239Phase 1
- SGI-110 Plus Durvalumab/Tremelimumab in SCLCCompletedNCT03085849Phase 1
- A Study to Evaluate SHR-1210 in Patients With Advanced or Metastatic NSCLCStatus unknownNCT03085069Phase 2
- Therapeutic Yoga and Resistance Exercise for Lung CancerCompletedNCT03084692Not applicable
- A Phase III Trial of Recombinant Human Apo-2 Ligand for InjectionStatus unknownNCT03083743Phase 3
- A Study of ASP8273 in Subjects With Non-small Cell Lung Cancer (NSCLC) Harboring Epidermal Growth Factor Receptor (EGFR) MutationsTerminatedNCT03082300Phase 1
- Circulating Tumor DNA in Surgical Lung Cancer PatientsStatus unknownNCT03081741
- A Study of APG-1252 in Patients With SCLC or Other Solid TumorsCompletedNCT03080311Phase 1
- Image-Guided Functional Lung Avoidance Thoracic Radiotherapy for Lung Cancer: A Single-Blind Randomized TrialStatus unknownNCT03077854Not applicable
- Pre-Post Study for Supporting Appropriate Implementation of Lung Cancer ScreeningCompletedNCT03077230Not applicable
- Pilot Study of Regional Lung VentilationCompletedNCT03077113Not applicable
- A Study Evaluating MM-310 in Patients With Solid TumorsStatus unknownNCT03076372Phase 1
- Targeted Treatment With Intercalated Radiotherapy in EGFR-mutant IIIA/IIIB NSCLCStatus unknownNCT03074864Phase 2/3
- Metformin Plus TKI Use in Patients With Non-Small Cell Lung CarcinomaStatus unknownNCT03071705Not applicable
- Preoperative Loading With Carbohydrates in Lung Cancer SurgeryStatus unknownNCT03070626Not applicable
- Microbiota and the Lung CancerActive, not recruitingNCT03068663Not applicable
- The Impact of Trimodal Prehabilitation Strategy on Patients Undergoing Thoracoscopic LobectomyCompletedNCT03068507Not applicable